{"DataElement":{"publicId":"7414237","version":"1","preferredName":"Pegaspargase Absolute Dose Administered","preferredDefinition":"An indicator for the absolute dose of Pegaspargase administered.","longName":"PEG_ABS_DOSE_ADMIN","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7414236","version":"1","preferredName":"Pegaspargase Absolute Dose Administered","preferredDefinition":"A complex of polyethylene glycol conjugated with L-asparaginase.  Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia, thereby depleting these cells of asparagine and blocking protein synthesis and tumor cell proliferation, especially in the G1 phase of the cell cycle.  The agent also induces apoptosis in tumor cells. Pegylation decreases the enzyme's antigenicity. Asparagine is critical to protein synthesis in leukemic cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. (NCI04)_Complete and without restriction or qualification; something that does not depend on anything else; not relative._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._The act of having given something (e.g., a medication or test).","longName":"7391860v1.0:7414234v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"7391860","version":"1","preferredName":"Pegaspargase","preferredDefinition":"A complex of polyethylene glycol conjugated with L-asparaginase.  Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia, thereby depleting these cells of asparagine and blocking protein synthesis and tumor cell proliferation, especially in the G1 phase of the cell cycle.  The agent also induces apoptosis in tumor cells. Pegylation decreases the enzyme's antigenicity. Asparagine is critical to protein synthesis in leukemic cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. (NCI04)","longName":"C1200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pegaspargase","conceptCode":"C1200","definition":"A complex of polyethylene glycol conjugated with L-asparaginase.  Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia, thereby depleting these cells of asparagine and blocking protein synthesis and tumor cell proliferation, especially in the G1 phase of the cell cycle.  The agent also induces apoptosis in tumor cells. Pegylation decreases the enzyme's antigenicity. Asparagine is critical to protein synthesis in leukemic cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACC9791F-8A7D-4343-E053-4EBD850AD386","latestVersionIndicator":"Yes","beginDate":"2020-08-13","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-08-13","modifiedBy":"ONEDATA","dateModified":"2020-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7414234","version":"1","preferredName":"Absolute Dose Administered","preferredDefinition":"Complete and without restriction or qualification; something that does not depend on anything else; not relative.:A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.:The act of having given something (e.g., a medication or test).","longName":"C45829:C25488:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Absolute","conceptCode":"C45829","definition":"Complete and without restriction or qualification; something that does not depend on anything else; not relative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEE47B7C-2468-41BF-E053-4EBD850AA00F","latestVersionIndicator":"Yes","beginDate":"2020-09-09","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-09","modifiedBy":"ONEDATA","dateModified":"2020-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEE47B7C-2479-41BF-E053-4EBD850AA00F","latestVersionIndicator":"Yes","beginDate":"2020-09-09","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-09","modifiedBy":"SETRAKIN","dateModified":"2020-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2182726","version":"2","preferredName":"Agent Dose","preferredDefinition":"The amount of agent taken at one time.","longName":"AGT_DOSE","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":"3","maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":"4","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008514","version":"1","preferredName":"DCP Conceptual Domain","preferredDefinition":"DCP Conceptual Domain","longName":"DCP","context":"DCP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A946859C-932E-4C16-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-08-28","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-28","modifiedBy":"MAESKEB","dateModified":"2004-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2432127","version":"1","preferredName":"Dose","preferredDefinition":"The amount of medicine taken, or radiation given, at one time.","longName":"C25488","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"061284D5-1977-0705-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-11-21","modifiedBy":"ONEDATA","dateModified":"2005-11-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"30FFF163-B852-B876-E050-BB89AD434BC7","latestVersionIndicator":"Yes","beginDate":"2004-04-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-04-21","modifiedBy":"KNABLEJ","dateModified":"2017-07-07","changeDescription":"7/7/17 jk transferred context and added registration status, CSI per Round 5 finalization task.  --- Versioned to update the Representation Term to the preferred.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"If capped, what was the absol","type":"Preferred Question Text","description":"If capped, what was the absolute dose given?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEE46A34-ED91-41C7-E053-4EBD850A40BB","latestVersionIndicator":"Yes","beginDate":"2020-09-09","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-09","modifiedBy":"SETRAKIN","dateModified":"2020-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}